News | Magnetic Resonance Imaging (MRI) | September 25, 2019

Colorado Orthopedic Clinic Adds Canon Medical Vantage Galan 3T MRI to Frisco Clinic Location

Installation is first step in new partnership that includes Canon sponsorship of The Vail Scientific Summit

Colorado Orthopedic Clinic Adds Canon Medical Vantage Galan 3T MRI to Frisco Clinic Location

September 25, 2019 – The Steadman Clinic has added Canon Medical Systems USA Inc.’s Vantage Galan 3T magnetic resonance (MR) system to the orthopedic clinic’s Frisco, Colo., location.

“Everyone at The Steadman Clinic is focused on providing the best service with the top-of-the-line technology,” said Kelly Adair, chief operating officer of the Steadman Clinic. “Our goal is to provide the same quality service at our Frisco location as we do at our headquarters in Vail. We want to do this not only through our world-class physicians and surgeons, but also with the diagnostic equipment that we have in place in Frisco.”

The quiet technology of the Vantage Galan 3T MR system reinforces the patient-centric theme.  Acoustic noise is reduced up to 99 percent. It also employs Canon Medical’s MR Theater technology, which creates a unique environment where patients hardly notice they are moving into the machine, helping to maximize comfort and put the patient at ease. Patients can watch movies or other videos in peace and quiet while the MR scanning takes place.

Placing the Vantage Galan 3T in the Frisco clinic was the first of many steps in establishing a solid, mutually beneficial partnership between Canon Medical and The Steadman Clinic/Steadman Philippon Research Institute (SPRI).

“As we went through the process of researching MR systems,” said Adair, “Canon Medical’s customer service and state-of-the-art equipment was superb. We are so pleased to have established a strategic partnership with Canon Medical. Our goals and Canon Medical’s are very similar — to provide the very best patient experience and utilize the most up-to-date and dynamic medical equipment available.

“Canon Medical is heavily invested in research and development, which makes it a perfect fit with The Steadman Clinic and SPRI,” continued Adair. “Canon Medical provides the technology and we add the evidence-based research that leads to better treatment methods and higher quality care for our patients.”

The strategic agreement and relationship with Canon Medical was advanced in late August, as Canon Medical became the first title sponsor in the five-year history of The Vail Scientific Summit.

“The Steadman Clinic and SPRI was very proud to have Canon Medical serve in this key sponsorship role,” said Adair. “The Annual Vail Scientific Summit is one of the premier medical and research conferences in the United States and clearly one of the highlights of our calendar each year here at SPRI. Canon Medical’s commitment and involvement in this unique event furthers the ability of our world-class research professionals to continue their ground-breaking work in the laboratories at SPRI and to share the knowledge and findings with the large number of physicians, clinicians and scientists from around the world that attend our event each August.”

For more information: www.us.medical.canon

Related Content

Flowchart of patient inclusion and exclusion.

Figure 1. Flowchart of patient inclusion and exclusion.

News | Coronavirus (COVID-19) | October 20, 2020
October 20, 2020 — A new multi-institutional study published in the journal ...
Ezra, a NY-based startup transforming early cancer screening using magnetic resonance imaging (MRI), announced that it has received FDA 510(k) premarket authorization for its Artificial Intelligence, designed to decrease the cost of MRI-based cancer screening, assisting radiologists in their analysis of prostate MRI scans. It is the first prostate AI to be cleared by the FDA.
News | Artificial Intelligence | October 20, 2020
October 20, 2020 — Ezra, a NY-based startup transforming early cancer screening using...
Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA)

56-Year-Old Woman With Benign Hemangioma: Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA) MR image shows lesion is homogeneously hyperintense compared with liver parenchyma.

News | Magnetic Resonance Imaging (MRI) | October 16, 2020
October 16, 2020 — 
Carestream Health will offer insights on technology, innovative new products and research in medical imaging through a new webinar series titled Carestream Talks. #RSNA20
News | Radiology Education | October 14, 2020
October 14, 2020 — Carestrea